Bristol-Myers Squibb (BMY) Tops Q1 EPS by 7c, Beats on Revenue
Tweet
Share
E-mail
Get Alerts BMY Hot Sheet
Price: $62.62 -0.7%
Revenue Growth %: +3.2%
Financial Fact:
Net Earnings Attributable to Bristol-Myers Squibb Company: 1.2B
Today's EPS Names:
ALZN, ASPU, OCCI, More
Revenue Growth %: +3.2%
Financial Fact:
Net Earnings Attributable to Bristol-Myers Squibb Company: 1.2B
Today's EPS Names:
ALZN, ASPU, OCCI, More
Join SI Premium – FREE
Bristol-Myers Squibb (NYSE: BMY) reported Q1 EPS of ($4.40), $0.07 better than the analyst estimate of ($4.47). Revenue for the quarter came in at $11.9 billion versus the consensus estimate of $11.46 billion.
For earnings history and earnings-related data on Bristol-Myers Squibb (BMY) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Microchip Technology completes acquisition of Hailo
- Raymond James Reiterates Underperform Rating on Lennar (LEN)
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
